Amneal Pharmaceuticals Class A financial statements

엠닐 파머슈티컬스NASDAQ:AMRX · Nasdaq · Healthcare · sector #16
$20.30-0.27%
2026-10-06 close · prelim

Amneal Pharmaceuticals Class A's published financial data is dated 2026-10-04. 2024 revenue was $2.79B. 2024 operating profit was $249M.

Reported results

Amneal Pharmaceuticals Class A notifications

Quantus Signal · live data · not investment advice · Privacy Policy
Q